Nanjing Pharmacare Co., Ltd

Nanjing Pharmacare Co., Ltd is engaged in the import-export business of formulations, APIs, Food supplements, Veterinary products, Medical device,Pharmaceutical Intermediates and Empty gelatin capsules. The market has covered Africa, South America, Southeast Asia, the CIS and the Middle East. Besides exclusive distribution right for strong APIs and empty gelatin capsules, Nanjing Pharmacare has more than 100 registration licenses of formulations in different countries and establishes close strategy relationship with the leading companies in these target markets,  which makes us to be a leading supplier from China for pharmaceutical products. Furthermore, Nanjing Pharmacare launches the first Chinese formulation - Salbutamol Inhaler in Brazil, while three formulation production lines have approved by ANVISA GMP inspection.

Nanjing Pharmacare has a young, professional, international team, from R&D, Regulatory affairs, Business Development and logistics, which makes a stable foundation for company rapid development.

Meanwhile, we will increase the investment in the registration of the formulations and APIs, in order to develop not only Non-regulatory market, also Regulatory market. At the same time, we will explore the new business model, including opening branch offices abroad, establish our own brand in the market.

Nanjing Pharmacare always pays great attention on team construction. We are strengthening the training of employees, but also to provide better development platform for employees. In the company management, we implement standardization, process and informational.